世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
腸管偽閉塞治療の世界市場、病態別（急性v/s慢性）、診断別（身体検査、生検、血液検査、胃排出試験、画像検査、その他）、治療別（投薬、手術、食事、その他）、エンドユーザー別（病院・クリニック、外来診療センター、その他）、地域別、競合予測＆機会、2017-2027年Global Intestinal Pseudo Obstruction Treatment Market, By Condition (Acute v/s Chronic), By Diagnosis (Physical Examination, Biopsy, Blood Test, Gastric Emptying Tests, Imaging Tests, Others), By Treatment (Medication, Surgery, Diet, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region, Competitional Forecast & Opportunities, 2017-2027 世界の腸管偽閉塞治療市場は、予測期間中に恐るべき速度で成長すると予想されています。この成長は、神経細胞が適切に機能しない場合に筋肉の障害によって胃腸の筋肉の収縮に障害が生じるまれな状態である偽閉塞... もっと見る
サマリー世界の腸管偽閉塞治療市場は、予測期間中に恐るべき速度で成長すると予想されています。この成長は、神経細胞が適切に機能しない場合に筋肉の障害によって胃腸の筋肉の収縮に障害が生じるまれな状態である偽閉塞に関連する複雑な事例の増加に起因していると考えられます。仮性腸閉塞は、治療しない場合、腹部の腫れや痛み、吐き気、便秘、下痢などを引き起こす可能性があります。ひどい場合には、食欲がなくなったり、栄養の吸収が悪くなり、栄養失調になることもあります。様々な胃の病気や消化不良などの発生率が急速に増加していることから、世界の腸管偽閉塞治療市場の成長を牽引すると期待されています。腸閉塞のリスクは、神経の変性や筋肉の異常により加齢とともに増加するため、世界的な老年人口の増加が腸閉塞治療市場の成長に寄与しています。技術の進歩や、腸管偽閉塞治療の製品や治療方法に対する研究イニシアチブの高まりは、今後5年間における偽閉塞治療市場の成長を促進すると予想される要因の一部です。胃腸の画像診断や臓器管のマノメトリーにおける新たな技術革新が、世界の腸管偽閉塞治療市場の成長を支えています。さらに、医療費の増加や、病気に対する意識を高めるための公的・民間組織による取り組みが拡大していることも、世界の腸管偽閉塞治療市場の成長を後押ししています。しかし、医療費の高騰や副作用の可能性が、予測期間中の世界の腸管偽閉塞治療市場の成長を妨げると予想されます。世界の腸管偽閉塞治療市場は、病態、診断、治療、エンドユーザー、地域分布、競合環境などに基づいて細分化されています。地域別では、北米が、健康関連の問題に対する意識の高まりと、同地域における充実した医療の存在により、世界の腸閉塞治療市場を支配すると予想されます。 世界の腸管偽閉塞治療市場を支配する主なプレーヤーは、ファイザー社、シプラ社、グラクソ・スミスクライン社、テバ・ファーマシューティカル・インダストリーズ社、イーライ・リリー・アンド・カンパニー社、ノバルティスAG、ジョンソン＆ジョンソン、ドクター・レディーズ・ラボラトリーズ社、Fホフマン-ラ・ロシュ社、ルパン社などです。 本レポートで考慮した年数 歴史的年数：2017年〜2020年 基準年：2021年 推定年: 2022E 予測期間：2023F-2027F 本調査の目的 - 2017年から2021年までの世界の腸管偽閉塞治療市場の市場規模における歴史的成長を分析すること。 - 2022Eから2027Fまでの世界の腸管偽閉塞治療市場の市場規模および2027Fまでの成長率を予測・推計すること。 - 症状、治療法、診断、エンドユーザー、地域、競合環境に基づいて世界の腸管偽性閉塞治療市場を分類・予測する。 - 世界の腸管偽性閉塞症治療市場における支配的な地域やセグメントを特定する。 - 世界の腸管偽性閉塞症治療市場の促進要因と課題を特定する。 - 世界の腸管偽性閉塞症治療市場における拡張、新製品発表、M&Aなどの競争的展開を検討する。 - 世界の腸管偽性障害治療市場で事業展開している主要企業のプロファイルを特定し、分析する。 - 世界の腸管偽性閉塞治療市場で市場参入企業が採用する持続可能な主要戦略を特定する。 レポートの範囲 本レポートでは、腸管偽閉塞治療の世界市場を、下記にも詳述した業界動向に加えて、以下のカテゴリーに分類しています。 - 腸管偽閉塞治療市場、状態別。 o 急性 o 慢性 - 腸管偽閉塞治療市場： 診断別。 o 身体検査 o 生検 o 血液検査 o 胃排出テスト o 画像検査 o その他 - 腸管偽閉塞の治療市場、治療別 o 薬物療法 o 外科手術 o 食事療法 o その他 - 腸管偽性阻血治療市場：エンドユーザー別 o 病院・診療所 o 外来診療センター o その他 - 腸管偽閉塞治療市場：地域別 o 北米 米国 メキシコ カナダ o ヨーロッパ フランス ドイツ イギリス イタリア スペイン o アジア太平洋地域 中国 インド 日本 韓国 オーストラリア o 中東・アフリカ 南アフリカ共和国 サウジアラビア UAE o 南米 ブラジル アルゼンチン コロンビア TechSci Researchは、この調査のために一次調査と徹底的な二次調査の両方を実施しました。まず、TechSci Research は世界中の企業のリストを入手しました。その後、TechSci Research は特定された企業に対して一次調査を実施しました。インタビューしながら、回答者には競合他社についても質問しました。この手法により、TechSci Research は、二次調査の制限により特定できなかった企業も含めることができました。TechSci Research は、世界中のすべての主要なプレーヤーの企業と存在を分析しました。 TechSci Researchは、様々なエンドユーザーセグメントのデータを記録し、将来の予測を行うボトムアップアプローチを用いて、世界の腸管偽性閉塞治療の市場規模を算出しました。TechSci Researchは、これらの値を業界の専門家や企業の代表者から入手し、適切で全体的な市場規模を得るためにこれらの治療の履歴データを分析することで外部的に検証しました。企業のウェブサイト、ニュース記事、プレスリリース、企業の年次報告書、投資家向けプレゼンテーション、財務報告書など、さまざまな二次資料もTechSci Researchによって調査されました。 主な対象読者 - 腸管偽閉塞の治療企業 - エンドユーザー - 規制当局や政策立案者などの政府機関 - 世界の腸管偽性閉塞治療市場に関連する組織、業界団体、フォーラム、アライアンス 本調査は、企業、パートナー、エンドユーザーなどの業界関係者にとって重要ないくつかの重要な質問に対する回答を提供し、投資戦略や市場機会の活用を可能にする上で有用です。 競合の状況 企業プロフィール。世界の腸管偽閉塞治療市場に存在する主要企業の詳細な分析。 利用可能なカスタマイズ。 TechSci Researchは与えられた市場データをもとに、企業の特定のニーズに応じたカスタマイズを提供します。本レポートでは、以下のカスタマイズが可能です。 企業情報 - 追加市場プレイヤーの詳細分析およびプロファイリング（最大5社）。 目次1. Service Overview2. Research Methodology 3. Executive Summary 4. Impact of COVID-19 on Global Intestinal Pseudo Obstruction Treatment Market 5. Voice of Customer 5.1. Factors Contributing to Intestinal Pseudo Obstruction 5.2. Commonly Observed Symptoms of Intestinal Pseudo Obstruction 5.3. Intestinal Pseudo Obstruction Prevalence, By Age Group 5.4. Intestinal Pseudo Obstruction Prevalence, By Gender 5.5. Commonly Used Diagnostic Procedures for Intestinal Pseudo Obstruction 5.6. Preference for Intestinal Pseudo Obstruction Treatment, By Type 5.7. Brand Awareness 6. Global Intestinal Pseudo Obstruction Treatment Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Condition (Acute v/s Chronic) 6.2.2. By Diagnosis (Physical Examination, Biopsy, Blood Test, Gastric Emptying Tests, Imaging Tests, Others) 6.2.3. By Treatment (Medication, Surgery, Diet, Others) 6.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others) 6.2.5. By Company (2021) 6.2.6. By Region 6.3. Market Map 7. North America Intestinal Pseudo Obstruction Treatment Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Condition 7.2.2. By Diagnosis 7.2.3. By Treatment 7.2.4. By End User 7.2.5. By Country 7.3. North America: Country Analysis 7.3.1. United States Intestinal Pseudo Obstruction Treatment Market Outlook 7.3.1.1. Market Size & Forecast 7.3.1.1.1. By Value 7.3.1.2. Market Share & Forecast 7.3.1.2.1. By Condition 7.3.1.2.2. By Diagnosis 7.3.1.2.3. By Treatment 7.3.1.2.4. By End User 7.3.2. Mexico Intestinal Pseudo Obstruction Treatment Market Outlook 7.3.2.1. Market Size & Forecast 7.3.2.1.1. By Value 7.3.2.2. Market Share & Forecast 7.3.2.2.1. By Condition 7.3.2.2.2. By Diagnosis 7.3.2.2.3. By Treatment 7.3.2.2.4. By End User 7.3.3. Canada Intestinal Pseudo Obstruction Treatment Market Outlook 7.3.3.1. Market Size & Forecast 7.3.3.1.1. By Value 7.3.3.2. Market Share & Forecast 7.3.3.2.1. By Condition 7.3.3.2.2. By Diagnosis 7.3.3.2.3. By Treatment 7.3.3.2.4. By End User 8. Europe Intestinal Pseudo Obstruction Treatment Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Condition 8.2.2. By Diagnosis 8.2.3. By Treatment 8.2.4. By End User 8.2.5. By Country 8.3. Europe: Country Analysis 8.3.1. France Intestinal Pseudo Obstruction Treatment Market Outlook 8.3.1.1. Market Size & Forecast 8.3.1.1.1. By Value 8.3.1.2. Market Share & Forecast 8.3.1.2.1. By Condition 8.3.1.2.2. By Diagnosis 8.3.1.2.3. By Treatment 8.3.1.2.4. By End User 8.3.2. Germany Intestinal Pseudo Obstruction Treatment Market Outlook 8.3.2.1. Market Size & Forecast 8.3.2.1.1. By Value 8.3.2.2. Market Share & Forecast 8.3.2.2.1. By Condition 8.3.2.2.2. By Diagnosis 8.3.2.2.3. By Treatment 8.3.2.2.4. By End User 8.3.3. United Kingdom Intestinal Pseudo Obstruction Treatment Market Outlook 8.3.3.1. Market Size & Forecast 8.3.3.1.1. By Value 8.3.3.2. Market Share & Forecast 8.3.3.2.1. By Condition 8.3.3.2.2. By Diagnosis 8.3.3.2.3. By Treatment 8.3.3.2.4. By End User 8.3.4. Italy Intestinal Pseudo Obstruction Treatment Market Outlook 8.3.4.1. Market Size & Forecast 8.3.4.1.1. By Value 8.3.4.2. Market Share & Forecast 8.3.4.2.1. By Condition 8.3.4.2.2. By Diagnosis 8.3.4.2.3. By Treatment 8.3.4.2.4. By End User 8.3.5. Spain Intestinal Pseudo Obstruction Treatment Market Outlook 8.3.5.1. Market Size & Forecast 8.3.5.1.1. By Value 8.3.5.2. Market Share & Forecast 8.3.5.2.1. By Condition 8.3.5.2.2. By Diagnosis 8.3.5.2.3. By Treatment 8.3.5.2.4. By End User 9. Asia-Pacific Intestinal Pseudo Obstruction Treatment Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value 9.2. Market Share & Forecast 9.2.1. By Condition 9.2.2. By Diagnosis 9.2.3. By Treatment 9.2.4. By End User 9.2.5. By Country 9.3. Asia-Pacific: Country Analysis 9.3.1. China Intestinal Pseudo Obstruction Treatment Market Outlook 9.3.1.1. Market Size & Forecast 9.3.1.1.1. By Value 9.3.1.2. Market Share & Forecast 9.3.1.2.1. By Condition 9.3.1.2.2. By Diagnosis 9.3.1.2.3. By Treatment 9.3.1.2.4. By End User 9.3.2. India Intestinal Pseudo Obstruction Treatment Market Outlook 9.3.2.1. Market Size & Forecast 9.3.2.1.1. By Value 9.3.2.2. Market Share & Forecast 9.3.2.2.1. By Condition 9.3.2.2.2. By Diagnosis 9.3.2.2.3. By Treatment 9.3.2.2.4. By End User 9.3.3. South Korea Intestinal Pseudo Obstruction Treatment Market Outlook 9.3.3.1. Market Size & Forecast 9.3.3.1.1. By Value 9.3.3.2. Market Share & Forecast 9.3.3.2.1. By Condition 9.3.3.2.2. By Diagnosis 9.3.3.2.3. By Treatment 9.3.3.2.4. By End User 9.3.4. Japan Intestinal Pseudo Obstruction Treatment Market Outlook 9.3.4.1. Market Size & Forecast 9.3.4.1.1. By Value 9.3.4.2. Market Share & Forecast 9.3.4.2.1. By Condition 9.3.4.2.2. By Diagnosis 9.3.4.2.3. By Treatment 9.3.4.2.4. By End User 9.3.5. Australia Intestinal Pseudo Obstruction Treatment Market Outlook 9.3.5.1. Market Size & Forecast 9.3.5.1.1. By Value 9.3.5.2. Market Share & Forecast 9.3.5.2.1. By Condition 9.3.5.2.2. By Diagnosis 9.3.5.2.3. By Treatment 9.3.5.2.4. By End User 10. South America Intestinal Pseudo Obstruction Treatment Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Condition 10.2.2. By Diagnosis 10.2.3. By Treatment 10.2.4. By End User 10.2.5. By Country 10.3. South America: Country Analysis 10.3.1. Brazil Intestinal Pseudo Obstruction Treatment Market Outlook 10.3.1.1. Market Size & Forecast 10.3.1.1.1. By Value 10.3.1.2. Market Share & Forecast 10.3.1.2.1. By Condition 10.3.1.2.2. By Diagnosis 10.3.1.2.3. By Treatment 10.3.1.2.4. By End User 10.3.2. Argentina Intestinal Pseudo Obstruction Treatment Market Outlook 10.3.2.1. Market Size & Forecast 10.3.2.1.1. By Value 10.3.2.2. Market Share & Forecast 10.3.2.2.1. By Condition 10.3.2.2.2. By Diagnosis 10.3.2.2.3. By Treatment 10.3.2.2.4. By End User 10.3.3. Colombia Intestinal Pseudo Obstruction Treatment Market Outlook 10.3.3.1. Market Size & Forecast 10.3.3.1.1. By Value 10.3.3.2. Market Share & Forecast 10.3.3.2.1. By Condition 10.3.3.2.2. By Diagnosis 10.3.3.2.3. By Treatment 10.3.3.2.4. By End User 11. Middle East and Africa Intestinal Pseudo Obstruction Treatment Market Outlook 11.1. Market Size & Forecast 11.1.1. By Value 11.2. Market Share & Forecast 11.2.1. By Condition 11.2.2. By Diagnosis 11.2.3. By Treatment 11.2.4. By End User 11.2.5. By Country 11.3. Middle East and Africa: Country Analysis 11.3.1. South Africa Intestinal Pseudo Obstruction Treatment Market Outlook 11.3.1.1. Market Size & Forecast 11.3.1.1.1. By Value 11.3.1.2. Market Share & Forecast 11.3.1.2.1. By Condition 11.3.1.2.2. By Diagnosis 11.3.1.2.3. By Treatment 11.3.1.2.4. By End User 11.3.2. Saudi Arabia Intestinal Pseudo Obstruction Treatment Market Outlook 11.3.2.1. Market Size & Forecast 11.3.2.1.1. By Value 11.3.2.2. Market Share & Forecast 11.3.2.2.1. By Condition 11.3.2.2.2. By Diagnosis 11.3.2.2.3. By Treatment 11.3.2.2.4. By End User 11.3.3. UAE Intestinal Pseudo Obstruction Treatment Market Outlook 11.3.3.1. Market Size & Forecast 11.3.3.1.1. By Value 11.3.3.2. Market Share & Forecast 11.3.3.2.1. By Condition 11.3.3.2.2. By Diagnosis 11.3.3.2.3. By Treatment 11.3.3.2.4. By End User 12. Market Dynamics 12.1. Drivers 12.2. Challenges 13. Market Trends & Developments 14. Competitive Landscape 14.1. Pfizer, Inc. 14.2. Cipla Inc. 14.3. GlaxoSmithKline Plc. 14.4. Teva Pharmaceutical Industries Ltd. 14.5. Eli Lilly and Company 14.6. Novartis AG 14.7. Johnson & Johnson 14.8. Dr. Reddy’s Laboratories Ltd. 14.9. F. Hoffmann-La Roche AG 14.10. Lupin Limited 15. Strategic Recommendations
SummaryGlobal intestinal pseudo obstruction treatment market is anticipated to grow at a formidable rate during the forecast period. The growth can be attributed to the increasing instances of complexities related to pseudo obstruction, a rare condition where muscle impairment causes disruption in the gastro-intestinal muscle contraction when neurons are not able to function properly. If untreated, the intestinal pseudo obstruction could cause abdominal swelling, pain, nausea, constipation, or diarrhea. In extreme conditions, people can lose their appetite or may find difficulty in nutrient absorption, which can lead to malnutrition. Rapidly increasing incidences of various stomach ailments, indigestion, and other diseases are expected to drive the growth of the global intestinal pseudo obstruction treatment market. The risk of pseudo obstruction increases with aging due to neural degeneration or muscle abnormalities, thus increasing geriatric population across the globe is contributing to the growth of intestinal pseudo obstruction treatment market. Increasing advancements in technology and rising research initiatives towards products and treatment methodologies for intestinal pseudo obstruction treatment are some of the factors expected to propel the growth of pseudo obstruction treatment market in the next five years. New innovations in gastro intestinal imaging and manometry of the organ tract are supporting the growth of the global intestinal pseudo obstruction treatment market. Furthermore, rising healthcare expenditure and growing initiatives by public and private organizations to enhance awareness about diseases are supporting the growth of the global intestinal pseudo obstruction treatment market. However, high cost of the medical treatment and its possible side-effects are expected to hinder the growth of the global intestinal pseudo obstruction treatment market during the forecast period. Table of Contents1. Service Overview2. Research Methodology 3. Executive Summary 4. Impact of COVID-19 on Global Intestinal Pseudo Obstruction Treatment Market 5. Voice of Customer 5.1. Factors Contributing to Intestinal Pseudo Obstruction 5.2. Commonly Observed Symptoms of Intestinal Pseudo Obstruction 5.3. Intestinal Pseudo Obstruction Prevalence, By Age Group 5.4. Intestinal Pseudo Obstruction Prevalence, By Gender 5.5. Commonly Used Diagnostic Procedures for Intestinal Pseudo Obstruction 5.6. Preference for Intestinal Pseudo Obstruction Treatment, By Type 5.7. Brand Awareness 6. Global Intestinal Pseudo Obstruction Treatment Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Condition (Acute v/s Chronic) 6.2.2. By Diagnosis (Physical Examination, Biopsy, Blood Test, Gastric Emptying Tests, Imaging Tests, Others) 6.2.3. By Treatment (Medication, Surgery, Diet, Others) 6.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others) 6.2.5. By Company (2021) 6.2.6. By Region 6.3. Market Map 7. North America Intestinal Pseudo Obstruction Treatment Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Condition 7.2.2. By Diagnosis 7.2.3. By Treatment 7.2.4. By End User 7.2.5. By Country 7.3. North America: Country Analysis 7.3.1. United States Intestinal Pseudo Obstruction Treatment Market Outlook 7.3.1.1. Market Size & Forecast 7.3.1.1.1. By Value 7.3.1.2. Market Share & Forecast 7.3.1.2.1. By Condition 7.3.1.2.2. By Diagnosis 7.3.1.2.3. By Treatment 7.3.1.2.4. By End User 7.3.2. Mexico Intestinal Pseudo Obstruction Treatment Market Outlook 7.3.2.1. Market Size & Forecast 7.3.2.1.1. By Value 7.3.2.2. Market Share & Forecast 7.3.2.2.1. By Condition 7.3.2.2.2. By Diagnosis 7.3.2.2.3. By Treatment 7.3.2.2.4. By End User 7.3.3. Canada Intestinal Pseudo Obstruction Treatment Market Outlook 7.3.3.1. Market Size & Forecast 7.3.3.1.1. By Value 7.3.3.2. Market Share & Forecast 7.3.3.2.1. By Condition 7.3.3.2.2. By Diagnosis 7.3.3.2.3. By Treatment 7.3.3.2.4. By End User 8. Europe Intestinal Pseudo Obstruction Treatment Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Condition 8.2.2. By Diagnosis 8.2.3. By Treatment 8.2.4. By End User 8.2.5. By Country 8.3. Europe: Country Analysis 8.3.1. France Intestinal Pseudo Obstruction Treatment Market Outlook 8.3.1.1. Market Size & Forecast 8.3.1.1.1. By Value 8.3.1.2. Market Share & Forecast 8.3.1.2.1. By Condition 8.3.1.2.2. By Diagnosis 8.3.1.2.3. By Treatment 8.3.1.2.4. By End User 8.3.2. Germany Intestinal Pseudo Obstruction Treatment Market Outlook 8.3.2.1. Market Size & Forecast 8.3.2.1.1. By Value 8.3.2.2. Market Share & Forecast 8.3.2.2.1. By Condition 8.3.2.2.2. By Diagnosis 8.3.2.2.3. By Treatment 8.3.2.2.4. By End User 8.3.3. United Kingdom Intestinal Pseudo Obstruction Treatment Market Outlook 8.3.3.1. Market Size & Forecast 8.3.3.1.1. By Value 8.3.3.2. Market Share & Forecast 8.3.3.2.1. By Condition 8.3.3.2.2. By Diagnosis 8.3.3.2.3. By Treatment 8.3.3.2.4. By End User 8.3.4. Italy Intestinal Pseudo Obstruction Treatment Market Outlook 8.3.4.1. Market Size & Forecast 8.3.4.1.1. By Value 8.3.4.2. Market Share & Forecast 8.3.4.2.1. By Condition 8.3.4.2.2. By Diagnosis 8.3.4.2.3. By Treatment 8.3.4.2.4. By End User 8.3.5. Spain Intestinal Pseudo Obstruction Treatment Market Outlook 8.3.5.1. Market Size & Forecast 8.3.5.1.1. By Value 8.3.5.2. Market Share & Forecast 8.3.5.2.1. By Condition 8.3.5.2.2. By Diagnosis 8.3.5.2.3. By Treatment 8.3.5.2.4. By End User 9. Asia-Pacific Intestinal Pseudo Obstruction Treatment Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value 9.2. Market Share & Forecast 9.2.1. By Condition 9.2.2. By Diagnosis 9.2.3. By Treatment 9.2.4. By End User 9.2.5. By Country 9.3. Asia-Pacific: Country Analysis 9.3.1. China Intestinal Pseudo Obstruction Treatment Market Outlook 9.3.1.1. Market Size & Forecast 9.3.1.1.1. By Value 9.3.1.2. Market Share & Forecast 9.3.1.2.1. By Condition 9.3.1.2.2. By Diagnosis 9.3.1.2.3. By Treatment 9.3.1.2.4. By End User 9.3.2. India Intestinal Pseudo Obstruction Treatment Market Outlook 9.3.2.1. Market Size & Forecast 9.3.2.1.1. By Value 9.3.2.2. Market Share & Forecast 9.3.2.2.1. By Condition 9.3.2.2.2. By Diagnosis 9.3.2.2.3. By Treatment 9.3.2.2.4. By End User 9.3.3. South Korea Intestinal Pseudo Obstruction Treatment Market Outlook 9.3.3.1. Market Size & Forecast 9.3.3.1.1. By Value 9.3.3.2. Market Share & Forecast 9.3.3.2.1. By Condition 9.3.3.2.2. By Diagnosis 9.3.3.2.3. By Treatment 9.3.3.2.4. By End User 9.3.4. Japan Intestinal Pseudo Obstruction Treatment Market Outlook 9.3.4.1. Market Size & Forecast 9.3.4.1.1. By Value 9.3.4.2. Market Share & Forecast 9.3.4.2.1. By Condition 9.3.4.2.2. By Diagnosis 9.3.4.2.3. By Treatment 9.3.4.2.4. By End User 9.3.5. Australia Intestinal Pseudo Obstruction Treatment Market Outlook 9.3.5.1. Market Size & Forecast 9.3.5.1.1. By Value 9.3.5.2. Market Share & Forecast 9.3.5.2.1. By Condition 9.3.5.2.2. By Diagnosis 9.3.5.2.3. By Treatment 9.3.5.2.4. By End User 10. South America Intestinal Pseudo Obstruction Treatment Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Condition 10.2.2. By Diagnosis 10.2.3. By Treatment 10.2.4. By End User 10.2.5. By Country 10.3. South America: Country Analysis 10.3.1. Brazil Intestinal Pseudo Obstruction Treatment Market Outlook 10.3.1.1. Market Size & Forecast 10.3.1.1.1. By Value 10.3.1.2. Market Share & Forecast 10.3.1.2.1. By Condition 10.3.1.2.2. By Diagnosis 10.3.1.2.3. By Treatment 10.3.1.2.4. By End User 10.3.2. Argentina Intestinal Pseudo Obstruction Treatment Market Outlook 10.3.2.1. Market Size & Forecast 10.3.2.1.1. By Value 10.3.2.2. Market Share & Forecast 10.3.2.2.1. By Condition 10.3.2.2.2. By Diagnosis 10.3.2.2.3. By Treatment 10.3.2.2.4. By End User 10.3.3. Colombia Intestinal Pseudo Obstruction Treatment Market Outlook 10.3.3.1. Market Size & Forecast 10.3.3.1.1. By Value 10.3.3.2. Market Share & Forecast 10.3.3.2.1. By Condition 10.3.3.2.2. By Diagnosis 10.3.3.2.3. By Treatment 10.3.3.2.4. By End User 11. Middle East and Africa Intestinal Pseudo Obstruction Treatment Market Outlook 11.1. Market Size & Forecast 11.1.1. By Value 11.2. Market Share & Forecast 11.2.1. By Condition 11.2.2. By Diagnosis 11.2.3. By Treatment 11.2.4. By End User 11.2.5. By Country 11.3. Middle East and Africa: Country Analysis 11.3.1. South Africa Intestinal Pseudo Obstruction Treatment Market Outlook 11.3.1.1. Market Size & Forecast 11.3.1.1.1. By Value 11.3.1.2. Market Share & Forecast 11.3.1.2.1. By Condition 11.3.1.2.2. By Diagnosis 11.3.1.2.3. By Treatment 11.3.1.2.4. By End User 11.3.2. Saudi Arabia Intestinal Pseudo Obstruction Treatment Market Outlook 11.3.2.1. Market Size & Forecast 11.3.2.1.1. By Value 11.3.2.2. Market Share & Forecast 11.3.2.2.1. By Condition 11.3.2.2.2. By Diagnosis 11.3.2.2.3. By Treatment 11.3.2.2.4. By End User 11.3.3. UAE Intestinal Pseudo Obstruction Treatment Market Outlook 11.3.3.1. Market Size & Forecast 11.3.3.1.1. By Value 11.3.3.2. Market Share & Forecast 11.3.3.2.1. By Condition 11.3.3.2.2. By Diagnosis 11.3.3.2.3. By Treatment 11.3.3.2.4. By End User 12. Market Dynamics 12.1. Drivers 12.2. Challenges 13. Market Trends & Developments 14. Competitive Landscape 14.1. Pfizer, Inc. 14.2. Cipla Inc. 14.3. GlaxoSmithKline Plc. 14.4. Teva Pharmaceutical Industries Ltd. 14.5. Eli Lilly and Company 14.6. Novartis AG 14.7. Johnson & Johnson 14.8. Dr. Reddy’s Laboratories Ltd. 14.9. F. Hoffmann-La Roche AG 14.10. Lupin Limited 15. Strategic Recommendations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（中枢神経系作用薬）の最新刊レポート
TechSci Research社の中枢神経系作用薬分野での最新刊レポート
本レポートと同じKEY WORD（acute）の最新刊レポート
よくあるご質問TechSci Research社はどのような調査会社ですか?テックサイリサーチ（TechSci Research）は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
